1-9 of 9
Keywords: Castration-resistant prostate cancer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Ye Chen, Tian Lan
Journal: Urologia Internationalis
Urol Int (2021) 105 (5-6): 337–353.
https://doi.org/10.1159/000510124
Published Online: 21 September 2020
... of therapeutic pressures. With regard to the fundamental importance of the androgen receptor (AR) in all stages of PCa from tumorigenesis to progression, AR is postulated to have a continued critical role in castration-resistant prostate cancer (CRPC). Suppression of AR signaling mediated by the full-length AR...
View article titled, Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer
Open the PDF for Molecular Origin, Expression Regulation, and Biological Function of Androgen Receptor Splicing Variant 7 in Prostate Cancer in another window
Journal Articles

Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Yasuhide Miyoshi, Shinichi Sakamoto, Takashi Kawahara, Koichi Uemura, Yumiko Yokomizo, Hiroji Uemura
Journal: Urologia Internationalis
Urol Int (2019) 103 (3): 279–284.
https://doi.org/10.1159/000502655
Published Online: 28 August 2019
... and overall survival (OS) in men with bone metastatic castration-resistant prostate cancer (CRPC). Methods: We retrospectively enrolled 32 men with bone metastatic CRPC who had received cabazitaxel. The correlation between ΔBSI from baseline to 16 weeks after starting cabazitaxel and OS was analyzed...
View article titled, Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer
Open the PDF for Correlation between Automated Bone Scan Index Change after Cabazitaxel and Survival among Men with Castration-Resistant Prostate Cancer in another window
Journal Articles

Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis

Available to Purchase
Subject Area:
Further Areas
Yangzhou Liu, Shankun Zhao, Jiamin Wang, Zhiguo Zhu, Lianmin Luo, Ermao Li, Fucai Tang, Zhigang Zhao
Journal: Urologia Internationalis
Urol Int (2019) 102 (4): 373–384.
https://doi.org/10.1159/000495512
Published Online: 05 December 2018
...Yangzhou Liu; Shankun Zhao; Jiamin Wang; Zhiguo Zhu; Lianmin Luo; Ermao Li; Fucai Tang; Zhigang Zhao Purpose: To evaluate whether serum neuroendocrine markers could effectively predict treatment outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC). Methods: The PubMed...
View article titled, Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis
Open the PDF for Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis in another window
Journal Articles

Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review

Available to Purchase
Subject Area:
Further Areas
Jost von Hardenberg, Maike Schwartz, Thorsten Werner, Stefan Fuxius, Arne Strauss, Thomas Stefan Worst, Philipp Nuhn, Christian Bolenz, Elmar Heinrich
Journal: Urologia Internationalis
Urol Int (2017) 99 (4): 414–421.
https://doi.org/10.1159/000477943
Published Online: 13 July 2017
...Jost von Hardenberg; Maike Schwartz; Thorsten Werner; Stefan Fuxius; Arne Strauss; Thomas Stefan Worst; Philipp Nuhn; Christian Bolenz; Elmar Heinrich Background: Limited data are available for the use of agents in metastatic castration-resistant prostate cancer (mCRPC) beyond the third-line. We...
View article titled, Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review
Open the PDF for Oncologic Response and Hospitalization Rate of Patients Receiving Cabazitaxel in the Fourth-Line and Beyond in Castration-Resistant Prostate Cancer: Analysis of a Retrospective Cohort and a Structured Literature Review in another window
Journal Articles

Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Rafal Turo, Kenny Tan, Helene Thygesen, Subramanian K. Sundaram, Rohit Chahal, Stephen Prescott, William R. Cross
Journal: Urologia Internationalis
Urol Int (2015) 94 (3): 307–312.
https://doi.org/10.1159/000365198
Published Online: 21 October 2014
... was fatigue, which occurred in 49 patients (25.3%). The second commonest adverse event was gynaecomastia, developed by 29 patients (14.9%). Twenty-eight patients (14.4%) developed peripheral swelling and 18 patients (9.3%) experienced nausea. Diethylstilboestrol Castration-resistant prostate cancer...
View article titled, Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer
Open the PDF for Diethylstilboestrol (1 mg) in the Management of Castration-Resistant Prostate Cancer in another window
Journal Articles

High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study

Available to Purchase
Subject Area:
Further Areas
Ali Shamseddine, Fadi S. Farhat, Elias Elias, Raja B. Khauli, Ahmad Saleh, Mohammad A. Bulbul
Journal: Urologia Internationalis
Urol Int (2013) 90 (1): 56–61.
https://doi.org/10.1159/000343780
Published Online: 08 November 2012
...Ali Shamseddine; Fadi S. Farhat; Elias Elias; Raja B. Khauli; Ahmad Saleh; Mohammad A. Bulbul Introduction: Docetaxel has become the standard chemotherapy for patients with castration-resistant prostate cancer (CRPC). We wanted to assess the efficacy and safety of a weekly high-dose calcitriol...
View article titled, High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study
Open the PDF for High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study in another window
Journal Articles

Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates

Available to Purchase
Subject Area:
Further Areas
Axel Heidenreich, Wim P.J. Witjes, Truls E. Bjerklund-Johansen, Anup Patel, for the EAU Research Foundation
Journal: Urologia Internationalis
Urol Int (2012) 89 (1): 30–38.
https://doi.org/10.1159/000338810
Published Online: 13 June 2012
..., instructions or products referred to in the content or advertisements. Castration-resistant prostate cancer Bone metastasis Androgen deprivation Europe Osteonecrosis of the jaw Renal insufficiency Zoledronic acid Ibandronate Clodronate Prostate cancer (PCa) is the most common cancer type...
View article titled, Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates
Open the PDF for Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates in another window
Journal Articles

Feasibility of Tri-Weekly Docetaxel-Based Chemotherapy for Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
Natsuki Takaha, Koji Okihara, Kazumi Kamoi, Fumiya Hongo, Tsuyoshi Iwata, Kimihiro Yano, Takashi Ueda, Ichiro Takeuchi, Takeshi Yamada, Akihiro Kawauchi, Tsuneharu Miki
Journal: Urologia Internationalis
Urol Int (2011) 87 (3): 263–269.
https://doi.org/10.1159/000328217
Published Online: 26 August 2011
..., instructions or products referred to in the content or advertisements. Docetaxel Dose intensity Relative dose intensity Elderly patients Castration-resistant prostate cancer 2 12 2010 7 04 2011 26 8 2011 Urologia Internationalis Original Paper Urol Int 2011;87:263 269 DOI...
View article titled, Feasibility of Tri-Weekly Docetaxel-Based Chemotherapy for Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer
Open the PDF for Feasibility of Tri-Weekly Docetaxel-Based Chemotherapy for Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer in another window
Journal Articles

Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle

Available to Purchase
Subject Area:
Further Areas
Ammad A. Farooqi, Shahzad Bhatti
Journal: Urologia Internationalis
Urol Int (2011) 87 (2): 127–133.
https://doi.org/10.1159/000327723
Published Online: 30 April 2011
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Castration-resistant prostate cancer Androgen deprivation therapy Review Review Urol Int 2011;87:127 133 DOI: 10.1159...
View article titled, Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle
Open the PDF for Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle in another window